Matches in Nanopublications for { ?s ?p "[MET immunostaining was seen in normal urothelium and was recorded in 459 of 560 analyzable urothelial carcinomas (82.0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP802775.RAecQ4S5CyyE_Z8xTalbWSe0t5c_ATRouyFoy-lWXOo-E130_assertion description "[MET immunostaining was seen in normal urothelium and was recorded in 459 of 560 analyzable urothelial carcinomas (82.0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802775.RAecQ4S5CyyE_Z8xTalbWSe0t5c_ATRouyFoy-lWXOo-E130_provenance.
- NP945718.RAW39Xe4cEwQu3jB3RcHlq16PCJoCAqanFg9sBp0uIiaM130_assertion description "[MET immunostaining was seen in normal urothelium and was recorded in 459 of 560 analyzable urothelial carcinomas (82.0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945718.RAW39Xe4cEwQu3jB3RcHlq16PCJoCAqanFg9sBp0uIiaM130_provenance.
- NP553878.RA2RFkR7JkcJDKfcFjpNBol0TFXRIbWBCCwSeStQFFUo4130_assertion description "[MET immunostaining was seen in normal urothelium and was recorded in 459 of 560 analyzable urothelial carcinomas (82.0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553878.RA2RFkR7JkcJDKfcFjpNBol0TFXRIbWBCCwSeStQFFUo4130_provenance.